BIOCYTOGEN-B (02315) announced that Mr. Liu Hongkang has been appointed as a non-executive director, effective February 12, 2026, until the conclusion of the second board of directors' term. The appointment was approved by shareholders at an extraordinary general meeting. During a board meeting held on January 27, 2026, the board reviewed and approved Mr. Liu's appointment to the audit committee and the strategic development committee, contingent upon shareholder approval of his role as non-executive director. His committee memberships will take effect from the date his election to the board is approved and will last until the end of the second board's term.